Up next

Autoplay

FDA approves new drug for migraine sufferers (ASL - 12.24.19)

4 Views • 08/28/25
Share
Side Effects
Side Effects
Subscribers
0

Transcript

The FDA has approved a new drug for those who suffer from migraines called "Ubrogepant."

On Monday the FDA announced the drug's approval.

It will be sold under the name Ubrelvy by the pharmaceutical company Allergan.

It could be an alternative for those who don't respond to or are unable to take medications now on the market.

Last month a study published that nausea, sleepiness and dry mouth were the most commonly reported side effects.

It's estimated that 40 million people in the U.S. and a billion worldwide suffer from migraines.

The Closed Caption version of this video can be found here: https://sign1news.com/2019/12/....24/sign1news-12-24-1

Sign1News is the first and only digital network, partnered with world news leader CNN, to offer on-line news and information in American Sign Language. Sign1News provides equal access to local, regional and national news and information to the Deaf and hard-of-hearing community via a daily post-produced broadcast. Sign1News: Your Life. Your Language.

Show more
0 Comments sort Sort By

Up next

Autoplay